Specific subtypes and transmission clusters for HIV could require targeted interventions to control spread of HIV that is ...

It is an ester-derived prodrug that is converted in vivo by serum and tissue esterases to tenofovir, an acyclic nucleoside phosphonate (nucleotide) that inhibits HIV reverse transcriptase.

Transposon Therapeutics, a biotechnology company developing a platform of novel, orally administered therapies for the treatment of neurodegenerative and aging-related diseases, including Alzheimer's ...

CRF: Circulating recombinant form; NNRTI: Non-nucleoside reverse-transcriptase inhibitor; NRTI: Nucleos(t)ide analog reverse-transcriptase inhibitor. Eight nucleos(t)ide analog reverse ...

ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering the creation of life-transforming genetic medicines, today appointed Amy Pooler, Ph.D., as Senior Vice President, Research ...

If you enjoy eating red meat, you might want to pay attention to new research linking it to cancer risk. A recent study ...

RNAConnect, a pioneering life science reagent company, today announced the launch of the UltraMarathonRT® Two-Step RT-PCR Kit, a next-generation solution for researchers conducting RNA-to-cDNA ...

In South Korea, this candidate has already proceeded to phase I and II trials. It works by regulating the production of human ...

Serum IL-17 levels were determined by ELISA. IL-17 mRNA expression was analysed by reverse transcriptase-polymerase chain reaction. Conclusions: IL-17 expression in the mucosa and serum was increased ...

Islatravir is Merck's investigational nucleoside reverse transcriptase translocation inhibitor under evaluation in multiple ongoing early and late-stage clinical studies in combination with other ...